Similar articles

• Methotrexate nephrotoxicity: Novel treatment, new approach.

  Iqbal S, Armaghani A, Aiyer R, Kazory A. Iqbal S, et al. J Oncol Pharm Pract. 2013 Dec;19(4):373-6. doi: 10.1177/1078155212473002. J Oncol Pharm Pract. 2013. PMID: 24255083
• Voraxaze treats toxic methotrexate levels.

  Belavic JM. Belavic JM. Nurse Pract. 2012 Sep 10;37(9):15-6. doi: 10.1097/01.NPR.0000418387.29477.16. Nurse Pract. 2012. PMID: 22922716 No abstract available.
• Glucarpidase following high-dose methotrexate: update on development.

  Patterson DM, Lee SM. Patterson DM, et al. Expert Opin Biol Ther. 2010 Jan;10(1):105-11. doi: 10.1517/14712590903468677. Expert Opin Biol Ther. 2010. PMID: 19925307 Review.
• Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.

  Phillips M, Smith W, Balan G, Ward S. Phillips M, et al. J Clin Pharmacol. 2008 Mar;48(3):279-84. doi: 10.1177/0091270007311571. Epub 2008 Jan 11. J Clin Pharmacol. 2008. PMID: 18192538 Clinical Trial.
• Glucarpidase for the treatment of life-threatening methotrexate overdose.

  Tuffaha HW, Al Omar S. Tuffaha HW, et al. Drugs Today (Barc). 2012 Nov;48(11):705-11. doi: 10.1358/dot.2012.48.11.1871575. Drugs Today (Barc). 2012. PMID: 23170306 Review.